Literature DB >> 17024217

Management of symptomatic choroidal naevi with photodynamic therapy.

P Rundle1, I Rennie.   

Abstract

BACKGROUND/AIMS: To describe the use of photodynamic therapy (PDT) in the management of symptomatic serous retinal detachment associated with choroidal naevi.
METHODS: Interventional case series. The records of seven patients with choroidal naevus and associated serous retinal detachment, treated with PDT were reviewed retrospectively. Main outcome measures were Snellen visual acuity, clinical appearance, and ocular tomographic findings.
RESULTS: All seven patients showed a reduction in the degree of serous detachment and symptomatic improvement. Five patients showed a corresponding improvement in visual acuity that persisted over a mean period of 9 months.
CONCLUSION: PDT appears to be effective in the management of serous retinal detachment associated with choroidal naevus.

Entities:  

Mesh:

Year:  2006        PMID: 17024217     DOI: 10.1038/sj.eye.6702623

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  5 in total

Review 1.  Lasers for the treatment of intraocular tumors.

Authors:  Samuel K Houston; Charles C Wykoff; Audina M Berrocal; Ditte J Hess; Timothy G Murray
Journal:  Lasers Med Sci       Date:  2013-05       Impact factor: 3.161

2.  Photodynamic therapy of symptomatic choroidal nevi.

Authors:  Luis Amselem; Kaan Gündüz; Alfredo Adan; Melisa Zişan Karslιoğlu; Amanda Rey; Noelia Sabater; Xavier Valldeperas
Journal:  Middle East Afr J Ophthalmol       Date:  2011-10

3.  Treatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab.

Authors:  Milena L Cavalcante; Victor M Villegas; Aaron S Gold; Ludimila L Cavalcante; Marcela Lonngi; Nisha V Shah; Timothy G Murray
Journal:  Clin Ophthalmol       Date:  2014-07-22

4.  Dramatic regression of presumed acquired retinal astrocytoma with photodynamic therapy.

Authors:  Samuray Tuncer; Zafer Cebeci
Journal:  Middle East Afr J Ophthalmol       Date:  2014 Jul-Sep

5.  Treatment response to intravitreal bevacizumab in small pigmented choroidal lesions with subretinal fluid.

Authors:  Junwon Lee; Hee Jung Kwon; Min Kim; Christopher Seungkyu Lee; Sung Chul Lee
Journal:  BMC Ophthalmol       Date:  2019-05-03       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.